Hospital admissions linked to cannabis-related psychosis have increased sharply in Victoria over the past decade, with new research highlighting growing mental health harms and rising pressure on the state’s healthcare system.
The Monash University study found hospital admissions where cannabis-related harm was the primary reason for treatment increased by 49 per cent between 2013-14 and 2022-23. Researchers identified 39,565 cannabis-related hospital admissions across Victorian public and private hospitals over the 10-year period.
Psychotic disorders emerged as the leading cause of cannabis-related admissions, accounting for 40.1 per cent of cases where cannabis harm was the principal diagnosis.
Lead author Myfanwy Graham, from the Monash Addiction Research Centre, said the findings reflected an increase in serious cannabis-related harms requiring hospital treatment.
“We’re seeing more people admitted to hospital with cannabis-related health problems, particularly severe mental health harms, such as psychosis,” Ms Graham said.
“Unlike emergency department visits, hospital admissions generally involve more serious or complex cases where patients need additional treatment or monitoring.”
According to the Australian Institute of Health and Welfare, cannabis is the most widely used illicit drug in Australia, however, the Monash researchers found young people remained the group most likely to be hospitalised, with men and boys aged 15 to 24 recording the highest admission rates, followed by women and girls of the same age.
While males accounted for the greatest number of admissions overall, admissions among females grew at a much faster rate. Hospitalisation rates for women and girls increased by 75.1 per cent over the decade, compared with 34.6 per cent among males.
“The significant rise in hospitalisations among women and girls is particularly concerning, and highlights the urgent need for targeted public health campaigns and earlier intervention strategies,” Ms Graham said.
The study also sheds light on the burden placed on hospitals. More than two-thirds of cannabis-related admissions involved stays longer than one day, with patients spending a median of seven days in hospital. More than 1,500 admissions required treatment in intensive care, accounting for almost 110,000 hours of ICU care.
Researchers noted admission rates peaked during 2020-21, coinciding with Victoria’s Covid-19 lockdowns. The study suggests pandemic-related mental health pressures, social isolation and continued cannabis availability may have contributed to the surge.
The authors noted that mental health and behavioural disorders accounted for the overwhelming majority of admissions where cannabis was identified as a contributing factor.
Ms Graham said the research provided important evidence for policymakers and health services planning future responses.
“The study findings provide essential evidence to inform clinical and policy responses. It also highlights an urgent need for research investment in real-time safety trend monitoring and to embed tailored risk detection tools in clinical workflows,” she said.
